Concepedia

Mirko Marabese

MM

Statistics

Publications

37

Citations

1.9K

H-Index

25

Active since

2001

Affiliations

Mario Negri Institute for Pharmacological Research(Current)

Fondazione IRCCS Istituto Nazionale dei Tumori

Istituti di Ricovero e Cura a Carattere Scientifico

University of Milan

Policlinico Umberto I

Mirko Marabese is an author at Mario Negri Institute for Pharmacological Research specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2001–2024

37

Publications

37

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

Marina Chiara Garassino, Olga Martelli, Massimo Broggini et al. · The Lancet Oncology · 2013 · 477 citations

, , +14

Oct‐4 Expression in Adult Human Differentiated Cells Challenges Its Role as a Pure Stem Cell Marker

Stefano Zangrossi, Mirko Marabese, Massimo Broggini et al. · Stem Cells · 2007 · 172 citations

, , +16

Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC

Massimo Moro, Elisa Caiola, Monica Ganzinelli et al. · Journal of Thoracic Oncology · 2018 · 107 citations · Full text

, , +12

<i>KRAS</i> mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy

Mirko Marabese, Monica Ganzinelli, Marina Chiara Garassino et al. · Oncotarget · 2015 · 91 citations · Full text

, , +14

Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells

Laura Brunelli, Elisa Caiola, Mirko Marabese et al. · Oncotarget · 2014 · 84 citations · Full text

, , +17

1–5 of 37